Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Herrera, Emilio A ^a   Verkerk, Misha M ^a   Derks, Jan B ^b   Giussani, Dino A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DEXAMETHASONE; PHENYLEPHRINE; THROMBOXANE; ANTIOXIDANT; GLUCOCORTICOID; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; POTASSIUM;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BIRTH WEIGHT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMUR; MALE; MORTALITY; MYOGRAPHY; NEWBORN; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; RAT; SURVIVAL; VASCULAR DISEASE; VASOCONSTRICTION; ANIMAL; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FEMALE; FEMORAL ARTERY; IN VITRO STUDY; PATHOPHYSIOLOGY; PERITONITIS; RANDOMIZATION; SURVIVAL RATE; TIME; WISTAR RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ASCORBIC ACID; BODY WEIGHT; CARDIOVASCULAR DISEASES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL ARTERY; GLUCOCORTICOIDS; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PERITONITIS; POTASSIUM; RANDOM ALLOCATION; RATS; RATS, WISTAR; SURVIVAL RATE; TIME FACTORS; VASOCONSTRICTION; VITAMIN E;

EID: 77949502477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009250     Document Type: Article

References (50)

1. Halliday HL, Ehrenkranz RA, Doyle LW (2009a) Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (1): CD001146.
2. Halliday HL, Ehrenkranz RA, Doyle LW (2009b) Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev (1): CD001145.
3. Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368.
4. Baraldi E, Filippone M (2007) Chronic lung disease after premature birth. N Engl J Med 357: 1946-1955.
5. Ballard PL, Ballard RA (1995) Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 173: 254-262.
6. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, et al. (2001) Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 344: 95-101.
7. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, et al. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304-1313.
8. He J, Varma A, Weissfeld LA, Devaskar SU (2004) Postnatal glucocorticoid exposure alters the adult phenotype. Am J Physiol Regul Integr Comp Physiol 287: R198-208.
9. Adler AR, Camm EJ, Hansell JA, Richter HG, Giussani DA (2009) Antioxidants diminish adverse effects of postnatal glucocorticoid treatment in the newborn rat. Neonatology;In press.
10. Bensky AS, Kothadia JM, Covitz W (1996) Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics 97: 818-821.
11. de Vries WB, van der Leij FR, Bakker JM, Kamphuis PJ, van Oosterhout MF, et al. (2002) Alterations in adult rat heart after neonatal dexamethasone therapy. Ped Res 52: 900-906.
12. de Vries WB, Bal MP, Homoet-van der Kraak P, Kamphuis PJ, van der Leij FR, et al. (2006) Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment. Basic Res Cardiol 101: 36-42.
13. Bal MP, de Vries WB, van der Leij FR, van Oosterhout MF, Berger RM, et al. (2005) Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: studies in 4-week-old prepubertal rats. Pediatr Res 58: 46-52.
14. Whitworth JA, Brown MA, Kelly JJ, Williamson PM (1995) Mechanisms of cortisol-induced hypertension in humans. Steroids 60: 76-80.
15. Handa M, Kondo K, Suzuki H, Saruta T (1984) Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension 6: 236-241.
16. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA (1992) Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 19: 567-574.
17. Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2: 1-12.
18. Suzuki T, Nakamura Y, Moriya T, Sasano H (2003) Effects of steroid hormones on vascular functions. Microsc Res Tech 60: 76-84.
19. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, et al. (2003) Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92: 81-87.
20. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, et al. (2002) The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 20: 1035-1043.
21. Tangalakis K, Lumbers ER, Moritz KM, Towstoless MK, Wintour EM (1992) Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol 77: 709-717.
22. Bennet L, Kozuma S, McGarrigle HH, Hanson MA (1999) Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep. Br J Obstet Gynaecol 106: 331-339.
23. Jellyman JK, Gardner DS, Edwards CM, Fowden AL, Giussani DA (2005) Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep. J Physiol 567: 673-688.
24. Segar JL, Roghair RD, Segar EM, Bailey MC, Scholz TD, et al. (2006) Early gestation dexamethasone alters baroreflex and vascular responses in newborn lambs before hypertension. Am J Physiol Regul Integr Comp Physiol 291: R481-488.
25. Roghair RD, Lamb FS, Miller FJ Jr, Scholz TD, Segar JL (2005) Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity. Am J Physiol Regul Integr Comp Physiol 288: R46-53.
26. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341: 339-341.
27. Molnar J, Howe DC, Nijland MJ, Nathanielsz PW (2003) Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J Physiol 547: 61-66.
28. Chen K, Keaney J (2004) Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium 11: 109-121.
29. Dröge W(2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
30. Katusic ZS (1996) Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20: 443-448.
31. Wallerath T, Witte K, Schäfer SC, Schwarz PM, Prellwitz W, et al. (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A 96: 13357-13362.
32. Schäfer SC, Wallerath T, Closs EI, Schmidt C, Schwarz PM (2005) Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 288: H436-444.
33. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA (1996) Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem 271: 23928-23937.
34. Bian X, Seidler FJ, Slotkin TA (1993) Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology 47: 109-117.
35. Tseng YT, Tucker MA, Kashiwai KT, Waschek JA, Padbury JF (1995) Regulation of beta 1-adrenoceptors by glucocorticoids and thyroid hormones in fetal sheep. Eur J Pharmacol 289: 353-359.
36. Sakaue M, Hoffman BB (1991) Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 88: 385-389.
37. Hayashi T, Nakai T, Miyabo S (1991) Glucocorticoids increase Ca2+ uptake and [3H]dihydropyridine binding in A7r5 vascular smooth muscle cells. Am J Physiol 261: C106-114.
38. Berk BC, Vallega G, Griendling KK, Gordon JB, Cragoe EJ Jr, et al. (1988) Effects of glucocorticoids on Na+/H+ exchange and growth in cultured vascular smooth muscle cells. J Cell Physiol 137: 391-401.
39. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ (1994) Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 93: 1243-1249.
40. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y (2000) Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102.
41. Gunnett CA, Lund DD, Chu Y, Brooks RM II, Faraci FM (2001) NO-dependent vasorelaxation is impaired after gene transfer of inducible NOsynthase. Arterioscler Thromb Vasc Biol 21: 1281-1287.
42. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA (2003) Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93: 280-291.
43. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP (2000) Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420.
44. Zhou XB, Arntz C, Kamm S, Motejlek K, Sausbier U (2001) A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 276: 43239-43245.
45. Thibeault DW, Heimes B, Rezaiekhaligh M, Mabry S (1993) Chronic modifications of lung and heart development in glucocorticoid-treated newborn rats exposed to hyperoxia or room air. Pediatr Pulmonol 16: 81-88.
46. Wise GE, Grier RL IV, Lumpkin SJ, Zhang Q (2001) Effects of dexamethasone on tooth eruption in rats: differences in incisor and molar eruption. Clin Anat 14: 204-209.
47. Oncu M, Gultekin F, Karaöz E, Altuntas I, Delibas N (2002) Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidants. Hum Exp Toxicol 21: 223-230.
48. Carr AC, Zhu BZ, Frei B (2000) Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87: 349-354.
49. Porter JP (2000) Contribution of central ANG II to acute stress-induced changes in baroreflex function in young rats. Am J Physiol 279: R1386-R1391.
50. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.